PATENT CLAIM ANALYSIS

Application Number: 16019982
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
Described herein are polymeric nanoparticles that include a therapeutic agent which is 2-(3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-5-yl)-N-(3-fluorophenyl)acetamide (also known as AZD1152 hqpa) or a pharmaceutically acceptable salt thereof, and methods of making and using such therapeutic nanoparticles.

Claim (Index 24):
The method of  claim 21 , wherein the cancer is a solid tumor cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.45455
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14485875', '15860881', '14656899', '15118737', '12485467']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7429890586329291
- 35 USC 102 Novelty (BERT): 0.571403808830672
- Combined Prediction Score: 0.7258305336527033
- Mean Citation Score: 362.319864
- Max Citation Score: 554.6718
- Similarity Product: 312.6735632625818

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test